←
Niko Klink131 posts
Niko Klink avatar

Niko Klink

@NikolasKlink

PhD candidate @Gerschlab at the CGC of the @MPImoph and @TU_Dortmund. Fascinated by drug discovery and all things Ubiquitin.

◷ Joined September 2022▧ 7 Photos and videos
MPI Dortmund avatar
⟳ Niko Klink retweeted
MPI Dortmund@mpimoph·5 May 2025

New Parkinson’s disease paper: Chimeric deubiquitinase engineering reveals structural basis for specific inhibition of USP30 and a framework for DUB ligandability - published by @MalteGersch group @maxplanckpress in @Nature Struct. & Mol. Biol. nature.com/articles/s41594-0…

Niko Klink avatar
Niko Klink@NikolasKlink·5 May 2025

Excited to share that our work on Parkinson's target USP30 has been published in Nature Structural & Molecular Biology! By combining DUB-domains onto USP30, we for the first time achieved crystallization with a small molecule (NK036) without Nanobodies! nature.com/articles/s41594-0…

Malte Gersch avatar
⟳ Niko Klink retweeted
Malte Gersch@MalteGersch·25 Nov 2024

Very excited to share that our manuscript on the "Discovery and mechanism of K63-linkage-directed deubiquitinase activity in USP53" was published today at Nature Chemical Biology @nchembio. Congratulations Kim, Kai, and all authors! nature.com/articles/s41589-0…

Post attachment

For all ubiquitin, deubiquitinase and chemical biology aficionados: Here's a preprint from the lab introducing 2 new active DUBs in humans & a unique type of DUB activity one would miss with the widely used panels of free ubiquitin chains. t.ly/GnRVv Thread👇(1/10)

CRC 1430 avatar
⟳ Niko Klink retweeted
CRC 1430@crc1430·25 Nov 2024

Tomorrow, November 26, we are looking forward to hosting @georg_e_winter from @CeMM_News, Austrian Academy of Sciences, Vienna, at @crc1430 @unidue. Join us for his exciting talk on small-molecule degraders!

Post attachment
Niko Klink avatar
Niko Klink@NikolasKlink·7 Nov 2024

I had such a great time at this years AEK autumn school on #degraders and bringing them towards clinical applications. Fantastic Talks from both academia and Industry. I learned alot, got to see old friends and made New ones. Im bringing home great memories and a bunch of notes!

Post attachment
Ubiquigent avatar
⟳ Niko Klink retweeted
Ubiquigent@ubiquigent·15 Oct 2024

We’re delighted to be partnering with @AlleoLabs to accelerate DUB-focused drug discovery! This collaboration will combine Alleo’s AI-based platform with our expertise in the DUB space to advance DUB-focused preclinical programmes. ➡ tinyurl.com/283d7o5o

Post attachment
MPI Dortmund avatar
⟳ Niko Klink retweeted
MPI Dortmund@mpimoph·4 Oct 2024

Long non-coding RNA GRASLND links melanoma differentiation and interferon-gamma response - published by the Imig group in @FrontiersIn Molecular Biosciences frontiersin.org/journals/mol…